Skip to content
Sunday 6 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,831.09
0.00%
DAX
26,046.40
+0.17%
CAC 40
8,278.77
-0.09%
STOXX 50
6,392.93
+0.16%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 05 February 2013 7:19 pm  |  Updated:  Thursday 30 May 2019 4:15 am

The need for returns is still driving investors into equities

By: KCS-content

Add as a preferred source on Google

MARKETS finally saw a sell off this week, as investors decided that discretion was possibly the better part of valour, and concluded that booking profits might be the thing to do.

On the basis that nobody ever got sacked for taking a profit, it is understandable that funds, which have generally had a tough time over the last few years, might want to lock in some of their good fortune before it disappears. That said, even after the reversal, the market is up over 6 per cent on the year to date. But investors might note that there are over 40 FTSE 100 index dividends due to go “ex” over the next month, and we may see some lightening of positions once payment dates have passed.

Overall, the question on everyone’s lips is whether the rally can really take hold and continue through 2013. It is always hard for markets to continue higher, day after day, as the psychological pressure builds on new entrants to avoid being the person who “buys the high”. Little market corrections, therefore, are meat and drink to those looking for a pull back to get in.

Underlying the moves is the need for return. Dividend yields for blue chip stocks are still over 4 per cent, which looks fantastic against returns on cash or bonds. It is also a simple fact that the Bank of England is unlikely to move rates aggressively higher for a good many years to come.

UK stocks have performed quite poorly over recent years against most of their international counterparts. A compounding effect has been the general weakness of the pound, which has not helped one jot. As a stark reminder of the global effects of currency moves, a UK investor in the German DAX would hardly have noticed any bear market at all. Even if he or she had bought at the highs of 2007, German euro holdings in sterling terms would still be up nearly 20 per cent. Compare this to a German investor in the UK who, over the same time period, would still be staring at a 25 per cent loss even after the rallies of the last few years.

What is curious is the oft-stated fact that most of the senior stocks in the FTSE are not UK focused at all. It is generally agreed that over 70 per cent of FTSE 100 business is actually overseas. You would have thought that a weak pound would have been good for UK stock prices. These are some of the reasons why advisers have been getting increasingly positive about the UK equity markets.

Unfortunately, all of the best intentions do not help if the market decides to go on one of its regular walkabouts. Every year, there seems to be a period when confidence flies out of the window. Last year it happened around May, 2011 ran into summer blues in August, and in 2010 it was May again. February has its fair share of “moments” (2007, 2008 and 2009 come to mind). But it is fair to say that most of our clients are ignoring any thoughts of negativity and are buying into any weakness. Time will tell if they are right.

It is true that the actual economic data has been pretty grim recently, although markets have generally ignored this. Investors playing on the long side will be hoping that this effect will continue until such time as the numbers turn prettier.

Simon Denham is chief executive of Capital Spreads. You can follow him on Twitter @DenhamSimon

While Capital Spreads attempts to ensure that the information herein is accurate at the date the information was produced, it does not guarantee the accuracy, timeliness, completeness, performance or fitness for a particular purpose of any of the information provided herein and under no circumstances are they to be considered an offer, solicitation to invest or be construed as giving investment advice.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Jobs and Money

Categories

  • Money

Trending Articles

  • Victoria Beckham owed £350,000 by Harvey Nichols

  • Iceland boss Richard Walker vows to set up shop on Falkland Islands

  • Don’t underestimate the free trade agreement Britain just joined

  • £74m for branded condoms? UK must stop spaffing cash on foreign aid

  • My stressful night at London’s ultra luxe £1k a night hotel where I found glass in my food

More from Morning Wire

  • Can the Capital Access Window finally revive AIM?

    Markets
    Trader monitoring multiple computer screens displaying stock market data, charts, and financial figures.
  • Surge in third-party funding sparks wave in FTSE shareholder lawsuits

    Lawsuit
    UK retail investors are eyeing emerging markets for potential higher returns amid tariff turmoil
  • Mortgage nightmare as investors price in three interest rate hikes 

    Economics
    Bank of England building on Threadneedle Street, London, showcasing its historic architecture and financial significance
  • FTSE 100 creeps closer to record high as investors dodge AI turmoil

    Markets
    The FTSE 100 enjoyed a 3-year record rally in the third quarter.
  • Retail investors are returning to UK markets

    Opinion
    Union Jack flag with Big Ben clock tower and Houses of Parliament in London, UK
  • IPOs aren’t the new meme stocks

    Opinion
    Elon Musk discussing SpaceX investment as Scottish Mortgages largest holding on a business news platform
  • Cox Capital To Expand Liquidity Solutions for Retail Investors in Private Markets

    Business Wire
  • Astrazeneca share price tumbles on $400bn megamerger talks

    Investing
    Astrazeneca headquarters with logo, reflecting commitment to reduce US medicine prices after Trump administration pressure
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook